The reactivation and increased expression of ERVK Env has been linked to the majority of malignant breast tumors (Wang-Johanning et al., 2012; Cegolon et al., 2013; Downey et al., 2014; Figure 2). The gene discussed is ERVW-1; the disease is breast cancer.